XML 52 R39.htm IDEA: XBRL DOCUMENT v3.21.2
Segment Reporting (Tables)
3 Months Ended
Sep. 30, 2021
Segment Reporting  
Segment financial information

Three Months Ended

September 30, 

2021

    

2020

(In thousands)

Consolidated revenue:

  

 

  

Aytu BioPharma

$

13,883

$

5,752

Aytu Consumer Health

 

8,014

 

7,768

Consolidated revenue

$

21,897

$

13,520

Consolidated net loss:

 

  

 

  

Aytu BioPharma

$

(26,457)

$

(2,950)

Aytu Consumer Health

 

(1,394)

 

(1,356)

Consolidated net loss

$

(27,851)

$

(4,306)

September 30, 

June 30, 

2021

2021

(In thousands)

Total assets:

 

  

 

  

Aytu BioPharma

$

198,685

$

236,449

Aytu Consumer Health

 

29,044

 

29,219

Consolidated assets

$

227,729

$

265,668